- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Drug utilization evaluation of anticancer drugs in a charitable hospital ; volume:40 ; number:01 ; year:2019 ; pages:105-110
Indian journal of medical & paediatric oncology ; 40, Heft 01 (2019), 105-110
- Contributor
-
Mathew, Maneesha
Mateti, Uday Venkat
Saj, Neethu
Philip, Malona Lilly
Shetty, Vijith
- DOI
-
10.4103/ijmpo.ijmpo_156_18
- URN
-
urn:nbn:de:101:1-2021081213530198305737
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mathew, Maneesha
- Mateti, Uday Venkat
- Saj, Neethu
- Philip, Malona Lilly
- Shetty, Vijith
Other Objects (12)
New anticancer drugs
CDK7 inhibitors as anticancer drugs
Empagliflozin: a potential anticancer drug
Neurological adverse reactions to anticancer drugs
Gold(III) compounds as anticancer drugs
Anticancer Drug Discovery: Role of Pharmacogenomics
Quantitative comparison of anticancer drug dispersal before and after introducing appropriate preparation procedures during anticancer drug preparation
Molecular aspects of anti-cancer drug action
Human tumour xenografts in anticancer drug development
Genotypes Affecting the Pharmacokinetics of Anticancer Drugs
Anticancer drug R&D landscape in China
Lignans: a versatile source of anticancer drugs
New anticancer drugs
CDK7 inhibitors as anticancer drugs
Empagliflozin: a potential anticancer drug
Neurological adverse reactions to anticancer drugs
Gold(III) compounds as anticancer drugs
Anticancer Drug Discovery: Role of Pharmacogenomics
Quantitative comparison of anticancer drug dispersal before and after introducing appropriate preparation procedures during anticancer drug preparation
Molecular aspects of anti-cancer drug action
Human tumour xenografts in anticancer drug development
Genotypes Affecting the Pharmacokinetics of Anticancer Drugs
Anticancer drug R&D landscape in China
Lignans: a versatile source of anticancer drugs
New anticancer drugs
CDK7 inhibitors as anticancer drugs
Empagliflozin: a potential anticancer drug
Neurological adverse reactions to anticancer drugs
Gold(III) compounds as anticancer drugs
Anticancer Drug Discovery: Role of Pharmacogenomics
Quantitative comparison of anticancer drug dispersal before and after introducing appropriate preparation procedures during anticancer drug preparation
Molecular aspects of anti-cancer drug action
Human tumour xenografts in anticancer drug development
Genotypes Affecting the Pharmacokinetics of Anticancer Drugs
Anticancer drug R&D landscape in China